Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patients.
Larrat S, Kulkarni O, Claude JB, Beugnot R, Blum MG, Fusillier K, Lupo J, Tremeaux P, Plages A, Marlu A, Duborjal H, Signori-Schmuck A, Francois O, Zarski JP, Morand P, Leroy V.
Larrat S, et al. Among authors: duborjal h.
J Clin Microbiol. 2015 Feb;53(2):389-97. doi: 10.1128/JCM.02547-14. Epub 2014 Nov 19.
J Clin Microbiol. 2015.
PMID: 25411182
Free PMC article.